Company Overview
Company Type: Public Company
Website: www.perimetermed.com
Number of Employees: 43
Ticker: PINK (TSXV)
Year Founded: 2013


Business Description
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT and B-series OCT. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. The company was founded in 2013 and is headquartered in Toronto, Canada.

Financial Information (Currency: CAD, in mm) 
Total Revenue
0.6
Market Capitalization
78.0
TEV/Total Revenue
98.6x
EBITDA
(13.9)
Total Enterprise Value
57.4
TEV/EBITDA
NM
EBIT
(14.5)
Cash & ST Invst.
20.9
P/Diluted EPS Before Extra
NM
Net Income
(12.7)
Total Debt
0.3
Price/Tang BV
4.0x
Capital Expenditure
(1.2)
Total Assets
27.8
Total Debt/EBITDA
NM
Currency in CAD in mm, LTM as of Jun-30-2023 TEV and Market Cap are calculated using a close price as of Oct-06-2023


Estimates Snapshot (Current Fiscal Year End: Dec-31-2023 | Currency: CAD)
Periodic Estimates
Current FQ
Current FQ+1
Current FY
Current FY+1
NTM
EPS (GAAP)
(0.08)
(0.08)
(0.37)
(0.38)
(0.38)
Revenue (mm)
0.20
0.27
0.80
2.56
1.82
EBITDA (mm)
(4.14)
(4.11)
(16.79)
(20.90)
(20.49)

Forward Multiples (Current FY)

Price/Earnings
NM
TEV/REV
71.98x
TEV/EBITDA
NM

Non-Periodic Estimates

Recommendation
Outperform (2.33)
Target Price
3.75
Potential Upside
212.50%


Key Professionals
Name
Title
Mendes, Adrian 
Chief Executive Officer
Berkeley, Andrew 
Co-Founder & Chief Innovation Officer
Brien, Sara 
Chief Financial Officer
Boon, Merle Thomas
Chief Operating Officer
Regts, Jodi 
Corporate Communications & Investor Relations Officer
Hodges, Adam 
Vice President of Sales & Marketing

Key Board Members
Name
Title
Foster, Suzanne M.
Independent Chairman
Mortimer, Ian C.
Independent Director
Cheung, Gordon 
Member of Advisory Board
Cleland, Hugh 
Independent Director
Davidson, Aaron 
Independent Director
James, Ted 
Member of Advisory Board
Kancherla, Anantha 
Director
Prendergast, Franklyn G.
Member of Advisory Board
Vose, Josh 
Director
Wilson, Brian C.
Member of Advisory Board


Primary Industry Classification
Diversified Metals and Mining


Primary Office Location
555 Richmond Street W. Suite 511 | Toronto, ON | M5V 3B1 | Canada
Phone: 214-845-5154   Fax: 972-587-7795

Current and Pending Investors
Epic Capital Management, Inc., MaRs Discovery District, Investment Arm, NorthSpring Capital Partners, Northview LifeSciences (Douglas Janzen), Pathfinder Asset Management Limited, Roadmap Capital Inc., The Social+Capital Partnership, L.L.C.

Prior Investors
The Health Technology Exchange

Stock Quote and Chart (Currency: CAD)
Last  (Delayed)
 1.20
Market Cap (mm)
78.0
Open
 1.18
Shares Out. (mm)
65.0
Previous Close
 1.20
Float %
51.6%
Change on Day
0.04
Shares Sold Short (mm)
-
Change % on Day
3.4%
Dividend Yield %
-
Day High/Low
 1.21/ 1.18
Diluted EPS Excl. Extra Items
(0.20)
52 wk High/Low
 2.05/ 1.10
P/Diluted EPS Before Extra
NM
Volume (mm)
0.01
Avg 3M Dly Vlm (mm)
0.03
Beta 5Y
0.89


 
Delayed Quote** | Last Updated on Oct-06-2023 12:00 AM (GMT-5)
TSXV:PINK - Common Stock


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Current and Pending Subsidiaries / Investments
Company Name
Business Description
Geography
Primary Industry
LTM Total Rev.($mm)
LFQ Total Assets ($mm)
LFQ Total Debt ($mm)
New World Resource Corp.
As of June 29, 2020, New World Resource Corp. was acquired by Perimeter Medical Imaging Inc., in a reverse merger transaction. New World Resource Corp. does not have significant operations. Previously, it was engaged in the exploration and development of mineral properties. The company was incorporated in 1983 and is based in Vancouver, Canada.

United States and Canada
Diversified Metals and Mining
-
2.00
0.00
Lithium-Potash Pastos Grandes Brine Project
Lithium-Potash Pastos Grandes Brine Project consist of lithium, potassium, boron, halite, gypsum, clay, ulexite, and calcite mineral reserves. The project is located in Bolivia.

Latin America and Caribbean
Diversified Metals and Mining
-
-
-
Nano One Materials Corp. (TSX:NANO)
Nano One Materials Corp. produces cathode active materials for lithium-ion battery applications in electric vehicles, energy storage systems, and consumer electronics applications. It also offers lithium iron phosphate cathode materials for automotive and non-automotive applications. The company is headquartered in Burnaby, Canada.

United States and Canada
Specialty Chemicals
0.00
38.00
1.00
New World Bolivia S.A
New World Bolivia S.A is based in Bolivia. New World Bolivia S.A operates as a subsidiary of New World Resource Corp.

Latin America and Caribbean
-
-
-
-
New World Resource Bolivia S.A.

Latin America and Caribbean
-
-
-
-
New World Resource US, Inc.

United States and Canada
-
-
-
-


Last 5 Transactions
Announced Date
Closed Date
Transaction Type
Role
Target
Buyer/Investors
Sellers
Size($mm)
Dec-15-2021
Jan-27-2022
Private Placement
Target
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
The Social+Capital Partnership, L.L.C.

38.31
Jun-12-2020
Jun-29-2020
Private Placement
Target
Perimeter Medical Imaging Inc. (nka:Perimeter Medical Imaging AI, Inc. (TSXV:PINK))


7.30
Mar-13-2019
Jun-29-2020
Merger/Acquisition
Buyer
New World Resource Corp.
Perimeter Medical Imaging Inc. (nka:Perimeter Medical Imaging AI, Inc. (TSXV:PINK))

-
Jul-22-2015
Jul-22-2015
Private Placement
Target
Perimeter Medical Imaging Inc. (nka:Perimeter Medical Imaging AI, Inc. (TSXV:PINK))
Roadmap Capital Inc.,Epic Capital Management, Inc.,Pathfinder Asset Management Limited,Northview LifeSciences

3.84
* denotes that the relationship is proprietary


Last 5 Key Developments
Date
Event Type
Headline
Sep-07-2023
Product-Related Announcements
Perimeter Medical Imaging AI, Inc. Announces Alignment with FDA on Key Elements of Ongoing Clinical Trial
Aug-29-2023
Earnings Calls
Perimeter Medical Imaging AI, Inc., Q2 2023 Earnings Call, Aug 29, 2023
Aug-17-2023
Client Announcements
Perimeter Medical Imaging Ai, Inc. Announces First Commercial Placement of Perimeter S-Series OCT in the State of Georgia
Jun-05-2023
Executive Changes - CEO
Perimeter Medical Imaging Ai, Inc. Announces Executive Changes
Jun-05-2023
Executive/Board Changes - Other
Perimeter Medical Imaging Ai, Inc. Announces Appointment of Josh Vose to its Board of Directors

M&A Advisors
Stikeman Elliott LLP


Advisors
Most Recent Auditor
KPMG Limited
M&A Advisors
Stikeman Elliott LLP


Most Recent Auditor
KPMG LLP - Klynveld Peat Marwick Goerdeler


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
The Economy Matters

01:54 AM
PINK
The Economy Matters
Reports
8
Lake Street Capital Markets, LLC
Takkinen, Frank James
Sep 01, 2023 08:39 AM
PINK
Perimeter Medical Imaging AI, Inc.  (PYNKF): Termination of Coverage
EPS Estimates*
4
Paradigm Capital, Inc.
McAuley, Scott
Aug 31, 2023 05:38 AM
PINK
PINK: Q2/23 Earnings ...
EPS Estimates*
5
Leede Jones Gable Inc
Loe, Douglas W.
Aug 17, 2023 03:43 PM
PINK
LJG: Healthcare & Biotechnology Weekly - August 18, 2023
Initiation of Coverage*
9
Smart Insider Ltd.

Jul 24, 2023 12:59 AM
PINK
Pilulka Lekarny A.S.: 1 director
Reporting Results*
1
Paradigm Capital, Inc.
McAuley, Scott
May 28, 2023 06:34 PM
PINK
PINK: Q1/23 Earnings - Strong Utilization ...
EPS Estimates*
5
Wright Investors' Service Inc.

May 23, 2023 01:40 AM
PINK
Flow of Funds Report for Perimeter Medical Imaging AI Inc - prepared by Wright Investors Service
Notes
66
Paradigm Capital, Inc.
McAuley, Scott
Apr 18, 2023 06:51 PM
PINK
PINK: Q4/22 Earnings, But No New Installations
Notes
4
Raymond James Ltd.
Sarugaser, Rahul
Apr 12, 2023 08:10 AM
PINK
PINK | Installed Base Now at 6 | AI Clin. Trial Top-Line ~4Q23 | Implies FDA Clearance ~2H24
EPS Estimates*
9
Lake Street Capital Markets, LLC
Takkinen, Frank James
Apr 12, 2023 05:13 AM
PINK
Perimeter Medical Imaging AI, Inc. (PYNKF): Slow And Steady Progress, Commercial Funnel Growing, Enrollment Progressing; Affirm Buy Rating But Lower PT To $3
EPS Estimates*
5


Ownership Summary

            Top Holders 
Holders by Type
Holder

Common Stock Equivalent Held

% of Total Shares Outstanding

Market Value (CAD in mm)

Position Date


Roadmap Capital Inc.

16,693,527

25.67

20.0

Sep-20-2022


The Social+Capital Partnership, L.L.C.

14,466,667

22.25

17.4

Sep-20-2022


Mortimer C.M.A., CPA, CMA, CPA, M.B.A., MBA, Ian C.

113,333

0.17

0.1

Mar-23-2023


North Growth Management Ltd.

98,000

0.15

0.1

Jun-30-2023


Davidson M.B.A., MBA, Aaron 

84,000

0.13

0.1

Mar-23-2023


Cleland CFA, Hugh 

69,800

0.11

0.1

Mar-23-2023


Foster, Suzanne M.

43,756

0.07

0.1

Mar-23-2023


Boon, Merle Thomas

5,450

0.01

0.0

Mar-23-2023


Sobotta, Jeremy 

0

0.00

0.0

Jun-15-2023


Holler M.D., Anthony F.

0

0.00

0.0

May-23-2023



 



Top Buyers
No Top Buyers data available.

Top Sellers
Sellers
Common Stock Equivalent Held
Change
Holler M.D., Anthony F.
0
(332,074)
Sobotta, Jeremy 
0
(73,492)


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
Date/Time
Headline
Source
Sep-13
Perimeter Medical Imaging AI Announces Issuance and Amendment of Options
PR Newswire
Sep-11
Perimeter Medical Imaging AI Strengthens Leadership Team with Appointment of Experienced MedTech Executive, Adam Hodges, as Vice President, Sales and Marketing
ENP Newswire


Company Coverage
This company is not on any Coverage List.

Products
AI Software/ Machine Learning (Future), Atlas Image Library, Optical Coherence Tomography, Tissue Immobilizer


Upcoming Events
Date/Time
Type
Nov-29-2023
Estimated Earnings Release Date (S&P Global Derived)
* Future Events are subject to change.


Recent Major Filings

Key Filings
Filed On
Period Date
Company Name
Source
Form Type
Size
Oct-05-2023
-
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
News Releases
229 KB
Sep-13-2023
-
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
News Releases
184 KB
Sep-08-2023
-
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
News Releases
189 KB
Sep-07-2023
-
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
News Releases
246 KB
Aug-29-2023
-
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
News Releases
269 KB
Aug-29-2023
Jun-30-2023
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
Interim Financial Statements
1 MB
Aug-22-2023
-
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
News Releases
224 KB
Aug-17-2023
-
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
News Releases
186 KB
Aug-16-2023
-
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
News Releases
189 KB
Jun-29-2023
Dec-31-2022
Perimeter Medical Imaging AI, Inc. (TSXV:PINK)
SEDAR
Statement of Executive Compensation
321 KB


Insider Trades
Holder Name
Trade Date Range
Security Type
Transacted Shares
Transaction Value Range (CAD)
Transaction Type
% Change
Source
Holler M.D., Anthony F. (Former Independent Director)
Nov-21-2022
Common Shares
15,000
21,024
Open Market Acquisition
4.73
Multiple
Cleland CFA, Hugh  (Independent Director)
Nov-17-2022
Common Shares
10,000
14,694
Open Market Acquisition
16.72
Multiple
Holler M.D., Anthony F. (Former Independent Director)
Oct-06-2022 - Oct-07-2022
Common Shares
317,074
-
Private Acquisition
(100.00)
Multiple
-
Oct-06-2022
Common Shares
233,749
-
Private Acquisition
-
Exchange Announcement
-
Oct-07-2022
Common Shares
83,325
-
Private Acquisition
-
Exchange Announcement
Davidson M.B.A., MBA, Aaron  (Independent Director)
Jan-26-2022
Common Shares
84,000
272,502
Private Acquisition
New
Multiple
Mortimer C.M.A., CPA, CMA, CPA, M.B.A., MBA, Ian C. (Independent Director)
Jan-26-2022
Common Shares
30,000
97,322
Private Acquisition
36.00
Multiple
Excluding Automatic Transactions
Key Board Members Details
Name
Title
Phone
Fax
Email
Foster, Suzanne M.
Independent Chairman
214-845-5154
972-587-7795

Mortimer, Ian C.
Independent Director
214-845-5154
972-587-7795

Cheung, Gordon 
Member of Advisory Board
214-845-5154
972-587-7795

Cleland, Hugh 
Independent Director
(416) 597-3101
972-587-7795

Davidson, Aaron 
Independent Director
(647) 476-1350
972-587-7795

James, Ted 
Member of Advisory Board
214-845-5154
972-587-7795

Kancherla, Anantha 
Director
214-845-5154
972-587-7795

Prendergast, Franklyn G.
Member of Advisory Board
214-845-5154
972-587-7795

Vose, Josh 
Director
214-845-5154
972-587-7795

Wilson, Brian C.
Member of Advisory Board
214-845-5154
972-587-7795

* denotes that the relationship is proprietary

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Mendes, Adrian 
Chief Executive Officer
214-845-5154
972-587-7795

Berkeley, Andrew 
Co-Founder & Chief Innovation Officer
+1 416-846-0042
972-587-7795
aberkeley@perimetermed.com
Brien, Sara 
Chief Financial Officer
214-845-5154
972-587-7795

Boon, Merle Thomas
Chief Operating Officer
214-845-5154
972-587-7795

Regts, Jodi 
Corporate Communications & Investor Relations Officer
469-743-1834
972-587-7795

Hodges, Adam 
Vice President of Sales & Marketing
214-845-5154
972-587-7795

* denotes that the relationship is proprietary

Historical Equity Pricing Data supplied by Interactive Data Pricing and Reference Data LLC 
S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 

**Intraday Quotes are delayed by at least 20 minutes.
